On Thursday, Shares of Keryx Biopharmaceuticals (NASDAQ:KERX), gained 3.93% to $10.31.
Keryx Biopharmaceuticals, declared that two national insurance providers have added Auryxia(TM) to their Medicare Part D formularies. Auryxia is the first and only absorbable, iron-based phosphate binder for the treatment of elevated serum phosphorus levels in people with chronic kidney disease on dialysis. Together, these new formularies will enhance unrestricted access to Auryxia, across Medicare Part D and commercial insurance providers, to about 65 percent of people in the U.S. presently taking phosphate binders.
“The inclusion of Auryxia on these major insurance providers’ Part D formularies, which we expect will start processing claims in the third quarter, significantly expands unrestricted access to Auryxia for people on dialysis and their caregivers,” said Greg Madison, Chief Executive Officer of Keryx Biopharmaceuticals. “We are progressing nicely towards our aim of broad, unrestricted access to about 80 percent of phosphate binder prescriptions, across both Medicare Part D and commercial insurance providers, within 12 months post-approval. Looking ahead, we are focused on ongoing to raise awareness of Auryxia’s clinical profile among the prescribing community and ensuring that the vast majority of dialysis patients have access to this important medicine.”
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes, in addition to treats iron deficiency anemia.
Shares of Credit Suisse Group AG (ADR) (NYSE:CS), declined -0.51% to $29.10, during its last trading session.
On June 15, 2015, the Credit Suisse NASDAQ Gold FLOWS 103 Index and the Credit Suisse NASDAQ Silver FLOWS 106 Index concluded the notional sale of options on GLD shares and SLV shares with July expiration. We expect that the notional cash distribution generated by this sale of options will be withdrawn from the Indices on July 13, 2015, subject to adjustment in the event of any market disruption events.
Assuming no redemption or acceleration of the ETNs and that the notional cash distribution is withdrawn from the Indices on July 13, 2015, we expect to declare a coupon of $0.0764 per ETN on the GLDI ETNs and a coupon of $0.0713 per ETN on the SLVO ETNs for payment on or around July 27, 2015, payable to the holder of record on July 22, 2015. The predictable coupon payment may be subject to change upon the occurrence of a disruption event or other unforeseen circumstances.
Credit Suisse Group AG, together with its auxiliaries, provides various financial services to private, corporate, institutional, government clients, and high-net-worth individuals, in addition to affluent and retail clients worldwide.
At the end of Thursday’s trade, Shares of Glu Mobile Inc. (NASDAQ:GLUU), gained 5.42% to $6.42.
Glu Mobile, declared that it will report its financial results for the second quarter ended June 30, 2015 after the U.S. markets close on Tuesday, August 4, 2015.
In conjunction with this declaration, Glu will host a conference call on August 4, 2015 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to talk about the company’s financial results.
Glu Mobile Inc. develops, publishes, and markets a portfolio of games for the smartphones and tablet devices users. The company offers free-to-play action, casual, racing, and sports genre mobile games.
Finally, Eastman Chemical Company (NYSE:EMN), ended its last trade with 0.45% gain, and closed at $79.63.
Eastman Chemical Company, declared LLumar has been named the official window tint and paint protection film of West Coast Customs, the world famous premiere vehicle customization shop internationally known for extraordinary builds, celebrity clients and the hit television show, West Coast Customs on the Fox Sports 2 Network. All custom builds in Season Three will feature LLumar window tint.
“It was natural for LLumar to team up with West Coast Customs, the premiere high-end modification shop,” said Mark Gershenson, Director, LLumar Global Brand Administration. “LLumar window tint adds style, protection and comfort to any ride; and our self-healing paint protection film assists keep West Coast Customs cars looking new. Now we can showcase window tint and paint protection film benefits to millions of West Coast Customs viewers.”
Eastman Chemical Company, a specialty chemical company, manufactures and sells materials, chemicals, and fibers in the United States and internationally. The company’s Additives & Functional Products segment offers solvents, such as specialty coalescents and ketones and esters, glycol ethers, and alcohol solvents; cellulose and polyester-based specialty polymers, and paint additives; insoluble sulfur products; antidegradants; hydrocarbon resins; specialty intermediates, performance products, and formic acid; and alkylamine derivatives.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
